Brief: Chong Kun Dang Pharmaceutical receives Europe patent

Chong Kun Dang Pharmaceutical

21/06/2018 02:58

June 21 (Reuters) - Chong Kun Dang Pharmaceutical Corp
 185750.KS  :
    * Says it received Europe patent for novel compounds as
histone
deacetylase 6 inhibitors and pharmaceutical compositions
comprising the same
    * Patent number is 15762410.7


    Source text in Korean : https://goo.gl/uhhunJ
    Further company coverage:  185750.KS 

 (Beijing Headline News)
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: hedy.cui.reuters.com@reuters.net))